Insider filing
Traded Sep 30 · filed 2 days later
Compensation award — excluded from discretionary-purchase analysis.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Sep 15, 2026 · Filed Sep 15, 2026
West Pharmaceutical Services's Sr. VP & Chief HR Officer sold $921K of West Pharmaceutical Services shares. The filing does not indicate a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market sale
Code S — open-market or private sale
~$921,260
Shares × reported transaction price
54 days after results of Jul 23, 2026, 44 days before results of Oct 29, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $365.00 on Sep 15, 2026, within 1% of its 52-week high, after a 5% rise over the previous 30 trading days
52-week range $230.95 (Feb 3, 2026) to $365.74 (Jul 2, 2026), 99% of the way up, from 251 adjusted closes. 30 trading days earlier: $347.94 on Aug 3, 2026. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
A securities lawsuit naming the company as a defendant was filed on May 5, 2025 in the U.S. District Court, E.D. Pennsylvania. A filing is an allegation, not a finding.
NEW ENGLAND TEAMSTERS PENSION FUND v. WEST PHARMACEUTICAL SERVICES, INC., docket 2:25-cv-02285, via CourtListener (court records). Nature of suit 850, company named as first defendant
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +3.8% | +1.8% | +2.0% |
| 30 days | +6.1% | +1.2% | +4.9% |
Past results only. Not a forecast.
Insider filing
Traded Sep 30 · filed 2 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Sep 11 · filed 4 days later
Derivative exercise or conversion — not an open-market buy.
Insider selling
Traded Sep 11 · filed 4 days laterNot reported under a pre-arranged trading plan
West Pharmaceutical Services's Sr. VP & Chief HR Officer sold $863K of West Pharmaceutical Services shares. The filing does not indicate a pre-arranged trading plan.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.